Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Cell Therapy
  6.  » Advancing Towards a Universal Platform for iPSC-Based Therapies

Advancing Towards a Universal Platform for iPSC-Based Therapies: An Interview with Boris Greber

Summary:  Human induced pluripotent stem cells (iPSCs) enable availability of next-generation cell therapies for broader patient population at a faster turnaround time for a variety of disease areas. Two Catalent Cell & Gene Therapy experts discuss the use of iPSCs as starting materials for cellular therapies, including the concept behind a universal platform for iPSC-based therapies.

Click here to download the Article